EyePoint Pharmaceuticals
EYPT
#10613
Rank
ยฃ20.37 M
Marketcap
ยฃ0.18
Share price
-11.36%
Change (1 day)
-98.29%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -ยฃ0.23 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ2.78 Million. In 2025 the company made an earning of -ยฃ0.18 Billion a decrease over its 2024 earnings that were of -ยฃ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.23 Billion29.31%
2025 -ยฃ0.18 Billion63.24%
2024 -ยฃ0.11 Billion104.29%
2023 -ยฃ53.11 Million-29.88%
2022 -ยฃ75.73 Million87.2%
2021 -ยฃ40.46 Million38.58%
2020 -ยฃ29.2 Million-24.56%
2019 -ยฃ38.7 Million
2017 -ยฃ17.65 Million22.59%
2016 -ยฃ14.4 Million-8.02%
2015 -ยฃ15.66 Million-296.09%
2014 ยฃ7.98 M-174.02%
2013 -ยฃ10.79 Million37.42%
2012 -ยฃ7.85 Million-56.29%
2011 -ยฃ17.96 Million-1062.38%
2010 ยฃ1.86 M-250.43%
2009 -ยฃ1.24 Million-89.5%
2008 -ยฃ11.82 Million
2005 -ยฃ7.29 Million56.99%
2004 -ยฃ4.64 Million73.7%
2003 -ยฃ2.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-ยฃ1.66 Million-99.29% Bahamas
NRC Health
NRC
ยฃ11.3 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA